Why PACS Group, Inc. (PACS) stock moved
Why PACS Group, Inc. (PACS) fell 7.1% today, November 19, 2026
PACS Group, Inc. (PACS) fell 7.1% on November 19, 2026, closing at $43.03 versus $46.30 the prior session (close-to-close, from daily closes). We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move occurred on elevated volume (3.2x the 5-day average) and took the stock to a new 30-day low. Source: FMP price data; BestStocks detection.
PACS Group, Inc. (PACS) moved -6.48% from $46.01 to $43.03 on 2026-11-19. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move occurred on elevated volume (3.2x the 5-day average) and took the stock to a new 30-day low.
What to watch next: PACS earnings on 2026-11-25; consensus EPS estimate is $0.58.
Earlier sessions that moved PACS
- −4.6%We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found.
- −4.1%We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found.
- +7.7%PACS Group filed a material event (8-K) and earnings report today, triggering a +6.67% intraday rally from $46.68 to $49.80. Read the November 4, 2026 analysis →
- −4.7%In the days prior, CEO Jason Murray sold 1,904 shares for $95,295.20 at $50.05 per share, and CAO Michelle Lewis sold 2,364 shares for $118,294.56 at $50.04 per share on October 29th.
- −3.8%After the Shareholders Foundation announced a pending lawsuit against the company in U.S. District Court for the Southern District of New York.
- +2.5%Driven by positive investor sentiment following the company's raised full-year 2026 guidance (revenue $5.75–5.85B, adjusted EBITDA $640–660M) and continued strategic expansion including the Eduro Healthcare transaction and a newly announced deal to acquire/manage 32 skilled nursing facilities in Florida, per the web synthesis.
- +4.1%We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found.
- +6.2%We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was identified.
- +4.4%Following recognition of its 17 post-acute communities in Newsweek's Best Nursing Homes for 2027 ranking.
- +4.3%PACS moved +4.26% from its $41.30 open to a $43.06 close on 2026-09-28.
- −5.5%We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
- +2.8%We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
- −3.4%Following disclosure of CEO Jason Hulse Murray's insider stock sale of $6.61 million (150,550 shares) on August 20–21 under a Rule 10b5-1 plan, combined with management's decision to hold share buybacks steady despite raising full-year 2026 revenue guidance in August (per finance.yahoo.com).
PACS Group, Inc. (PACS) shares tumbled 7.1% to $43.03 as of November 20, 2026, a significant decline from the prior close of $46.30. BestStocks flagged the session as a major change for PACS. The move is tied to price move down. Below, we break down what changed for PACS, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
PACS fell 7.1% to $43.03
PACS tumbled 7.1% in its latest session, moving from $46.30 to $43.03.
What it means for PACS Group, Inc. investors
For PACS Group, Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Positive price momentum; Positive price momentum. Weighing against that: Material negative event; Sharp 7.1% decline — elevated risk. Wall Street's consensus price target sits at $61.00, implying +41.8% upside from $43.03. BestStocks rates the overall signal quality medium (69/100). With earnings roughly 97 days out, the next report is the most likely near-term test of the move.
PACS price reaction
PACS last traded at $43.03, down $3.27 (-7.06%) from the previous close of $46.30. The session traded on 2.2× average volume (very high), so the move carried above-average conviction.
Bullish and bearish analyst opinions on PACS Group, Inc. (PACS)
The consensus analyst price target on PACS Group, Inc. (PACS) is $61.00, 41.8% above the recent $43.03. Over the past 90 days analysts logged 0 upgrades, 4 maintains, and 0 downgrades. Here is how the bullish and bearish cases on PACS line up.
The bullish case
- Wall Street's consensus price target of $61.00 implies +41.8% upside from $43.03.
- The Street's most bullish target is $62.00 (+44.1%).
- Positive price momentum.
The bearish case
- Material negative event.
- Sharp 7.1% decline — elevated risk.
- High volume 2.2x on decline — distribution signal.
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Nov 19, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for PACS
Frequently asked questions about PACS
Why did PACS Group, Inc. (PACS) stock move?
PACS Group, Inc. (PACS) fell 7.1% on November 19, 2026, closing at $43.03 versus $46.30 the prior session (close-to-close, from daily closes). We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move occurred on elevated volume (3.2x the 5-day average) and took the stock to a new 30-day low. Source: FMP price data; BestStocks detection.
How much did PACS stock fall?
PACS lost 7.06% ($3.27) versus the prior close of $46.30, last trading at $43.03 on 2.2× average volume.
When is PACS Group, Inc.'s next earnings date?
PACS's next earnings report is estimated for 2027-02-25 — about 97 days away.
What is the analyst price target for PACS?
The consensus analyst price target for PACS is $61.00, about 41.8% above the current $43.03. Over the past 90 days, analysts recorded 0 upgrades, 4 maintains, and 0 downgrades.
How BestStocks tracks PACS
This page is generated automatically by BestStocks' change-detection system after price move down was detected and verified against independent data sources. It draws on 20 tracked change events for PACS, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 20, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
